Luyan Pharma Co.,Ltd. (002788.SZ)
CNY 8.03
(-0.99%)
CNY 8.03
(-0.99%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 19.84 Billion CNY | 1.97% |
| 2022 | 19.46 Billion CNY | 10.93% |
| 2021 | 17.54 Billion CNY | 12.97% |
| 2020 | 15.53 Billion CNY | 3.48% |
| 2019 | 15 Billion CNY | 30.5% |
| 2018 | 11.5 Billion CNY | 37.93% |
| 2017 | 8.33 Billion CNY | 19.41% |
| 2016 | 6.98 Billion CNY | 5.39% |
| 2015 | 6.62 Billion CNY | 5.17% |
| 2014 | 6.29 Billion CNY | 14.13% |
| 2013 | 5.51 Billion CNY | 17.76% |
| 2012 | 4.68 Billion CNY | 58.97% |
| 2011 | 2.94 Billion CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 5.13 Billion CNY | 1.29% |
| 2024 Q2 | 5.15 Billion CNY | 0.44% |
| 2024 Q3 | 5.1 Billion CNY | -0.98% |
| 2023 Q2 | 5.18 Billion CNY | 7.05% |
| 2023 Q4 | 5.07 Billion CNY | 6.72% |
| 2023 FY | 19.84 Billion CNY | 1.97% |
| 2023 Q3 | 4.75 Billion CNY | -8.33% |
| 2023 Q1 | 4.84 Billion CNY | -5.78% |
| 2022 Q3 | 4.98 Billion CNY | 5.94% |
| 2022 FY | 19.46 Billion CNY | 10.93% |
| 2022 Q4 | 5.13 Billion CNY | 3.13% |
| 2022 Q2 | 4.7 Billion CNY | 1.43% |
| 2022 Q1 | 4.63 Billion CNY | 2.07% |
| 2021 FY | 17.54 Billion CNY | 12.97% |
| 2021 Q3 | 4.52 Billion CNY | 5.09% |
| 2021 Q4 | 4.54 Billion CNY | 0.33% |
| 2021 Q2 | 4.3 Billion CNY | 3.45% |
| 2021 Q1 | 4.16 Billion CNY | 0.9% |
| 2020 Q3 | 4.18 Billion CNY | 8.67% |
| 2020 Q2 | 3.85 Billion CNY | 14.67% |
| 2020 FY | 15.53 Billion CNY | 3.48% |
| 2020 Q1 | 3.36 Billion CNY | -13.4% |
| 2020 Q4 | 4.12 Billion CNY | -1.43% |
| 2019 Q3 | 3.95 Billion CNY | 5.58% |
| 2019 FY | 15 Billion CNY | 30.5% |
| 2019 Q2 | 3.74 Billion CNY | 9.28% |
| 2019 Q1 | 3.42 Billion CNY | 10.72% |
| 2019 Q4 | 3.88 Billion CNY | -1.86% |
| 2018 Q2 | 2.71 Billion CNY | 4.4% |
| 2018 Q4 | 3.09 Billion CNY | 0.16% |
| 2018 FY | 11.5 Billion CNY | 37.93% |
| 2018 Q3 | 3.09 Billion CNY | 13.87% |
| 2018 Q1 | 2.59 Billion CNY | 10.64% |
| 2017 Q1 | 1.62 Billion CNY | -5.54% |
| 2017 FY | 8.33 Billion CNY | 19.41% |
| 2017 Q3 | 2.33 Billion CNY | 15.0% |
| 2017 Q4 | 2.34 Billion CNY | 0.61% |
| 2017 Q2 | 2.03 Billion CNY | 25.24% |
| 2016 Q1 | 1.6 Billion CNY | -7.27% |
| 2016 Q2 | 1.8 Billion CNY | 12.54% |
| 2016 Q4 | 1.71 Billion CNY | -7.59% |
| 2016 FY | 6.98 Billion CNY | 5.39% |
| 2016 Q3 | 1.85 Billion CNY | 2.95% |
| 2015 Q4 | 1.72 Billion CNY | -0.46% |
| 2015 Q1 | 1.48 Billion CNY | 0.0% |
| 2015 Q3 | 1.73 Billion CNY | 3.94% |
| 2015 FY | 6.62 Billion CNY | 5.17% |
| 2015 Q2 | 1.67 Billion CNY | 12.32% |
| 2014 FY | 6.29 Billion CNY | 14.13% |
| 2013 FY | 5.51 Billion CNY | 17.76% |
| 2012 FY | 4.68 Billion CNY | 58.97% |
| 2011 FY | 2.94 Billion CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 29.99 Billion CNY | 33.84% |
| Yixintang Pharmaceutical Group Co., Ltd. | 17.3 Billion CNY | -14.705% |
| ZJAMP Group Co., Ltd. | 40.94 Billion CNY | 51.527% |
| Ji Yao Holding Group Co., Ltd. | 346.1 Million CNY | -5633.938% |